Welcome to our dedicated page for Bath & Body Works SEC filings (Ticker: BBWI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bath & Body Works, Inc. filings document the public-company record for a Delaware specialty retailer whose common stock trades on the New York Stock Exchange under BBWI. Recent 8-K reports furnish quarterly and full-year operating results, earnings guidance, Regulation FD disclosures, debt redemption notices and executive officer changes.
Proxy materials describe board oversight, director elections, executive compensation, shareholder voting matters and governance practices tied to the company’s Consumer First Formula, brand, product, supply chain and store assets. The filings also identify registered common stock, senior notes disclosures and capital-structure matters for a personal care and home fragrance retail business.
Bath & Body Works, Inc. (BBWI) director purchased additional company stock in the open market. On 11/21/2025, the reporting person bought 20,000 shares of common stock at a price of $15.035 per share, coded as a purchase transaction ("P").
After this transaction, the director beneficially owned 33,925 shares of Bath & Body Works common stock, held directly. The filing notes that the form was submitted for a single reporting person and was signed by an attorney-in-fact on 11/24/2025.
Bath & Body Works, Inc. (BBWI) director reported an open-market stock purchase. On 11/21/2025, the director bought 6,700 shares of common stock at a price of $14.855 per share. After this transaction, the director directly owns 48,175 shares of BBWI common stock. Additional indirect holdings include 12,925 shares held by the director's spouse and 9,900 shares each held in the Patricia M. Steinour Legacy Trust dated 10/14/2016 and the Stephen D. Steinour Dynasty Trust dated 6/1/2016. No derivative securities were reported.
Bath & Body Works, Inc. (BBWI) director reports open-market stock purchase. A director acquired 3,343 shares of common stock of Bath & Body Works, Inc. on 11/21/2025 in a reported purchase transaction at a price of $14.995 per share. Following this transaction, the director directly holds 21,554 shares of BBWI common stock. This filing is a routine Form 4 disclosure of insider share ownership and recent trading activity.
Bath & Body Works, Inc. (BBWI) director reported an open-market purchase of common stock. On 11/21/2025, the reporting person bought 3,469.552 shares of Bath & Body Works common stock at a weighted average price of $14.4 per share, coded as a purchase ("P").
After this transaction, the director beneficially owns 17,481.552 shares held directly. The price represents a weighted average, with individual purchase prices ranging from $14.40 to $14.425, and detailed breakdowns are available upon request to the company, the SEC staff, or a security holder.
Bath & Body Works (BBWI) reported a weaker third quarter of 2025 and outlined a major turnaround plan. Net sales slipped to $1.594 billion from $1.610 billion as stronger store and international sales could not offset a 7% decline in direct channel revenue. Gross margin compressed to 41.3% from 43.5% due to tariffs and heavier promotions, while operating income fell to $161 million from $218 million. Net income dropped to $77 million, or $0.37 per diluted share, versus $106 million, or $0.49, a year earlier.
Year-to-date, sales edged up 1.1% to $4.567 billion, but operating income and net income declined to $527 million and $246 million, respectively. The company generated $225 million of operating cash flow, spent $174 million on capex, repurchased $343 million of stock, and paid $126 million in dividends, ending the period with $236 million in cash and $3.890 billion of long-term debt. Management launched “The Consumer First Formula,” targeting $250 million of cost savings over the next two years to fund growth initiatives in product, brand, and marketplace expansion.
Bath & Body Works, Inc. reported that it has released its unaudited financial results for the third quarter of 2025 and provided earnings guidance for the fourth quarter of 2025. The company also updated its earnings guidance for the full year 2025, giving investors a view of how management currently expects the rest of the year to unfold.
These details are contained in a press release dated November 20, 2025, which is included as an exhibit to this report and incorporated by reference. The information is being furnished under the sections covering results of operations and Regulation FD disclosure, meaning it is intended to keep the market broadly informed but is not treated as being formally filed under certain liability provisions.
Bath & Body Works Inc. (BBWI) — Schedule 13G/A update: FMR LLC and Abigail P. Johnson filed Amendment No. 1 reporting beneficial ownership of 17,176,068.05 shares of BBWI common stock, representing 8.3% of the class as of the event date.
FMR reports sole voting power over 17,065,906.57 shares and sole dispositive power over 17,176,068.05 shares, with no shared voting or dispositive power. Abigail P. Johnson reports sole dispositive power over 17,176,068.05 shares and no voting power.
The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The date of event is September 30, 2025. The filing notes that one or more other persons may have rights to dividends or sale proceeds, and that no single such interest exceeds 5% of the class.
Victory Capital Management, Inc. filed Amendment No. 2 to Schedule 13G reporting beneficial ownership of 8,405,430 shares of Bath & Body Works (BBWI) common stock, representing 4.08% of the class as of 09/30/2025.
The filer reports sole voting power over 8,240,779 shares and sole dispositive power over 8,405,430 shares, with no shared voting or dispositive power. The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Bath & Body Works, Inc. (BBWI) reported second quarter 2025 Net Sales of $1,549 million, up $23 million or 1.5% versus Q2 2024, driven by modest increases in transactions and average dollar sales in North America. Operating Income was $157 million, down $26 million or 13.9%, and the operating margin fell to 10.2% from 12.0% a year earlier primarily due to higher general, administrative and store operating expenses related to leadership transition costs, partially offset by a higher gross profit rate. The Company recorded a much higher effective tax rate in Q2 2025 of 32.3% versus 0.9% in Q2 2024, reflecting severance-related items and other tax items; year-to-date rates were 29.9% versus 12.1% in the prior year. The Company had no borrowings under its $750 million ABL Facility as of August 2, 2025, with a borrowing base of $683 million and available capacity of $674 million after $9 million of letters of credit. The Company cancelled the remaining $121 million authorization under its January 2024 repurchase program on February 27, 2025 and began repurchases under a January 2025 program, with $3 million repurchased as of August 2, 2025 and $262 million remaining authority. Easton real estate investments were reclassified during Q2 2025, with held-for-sale carrying value movements and prior 2024 sales that generated $50 million of proceeds and a $39 million pre-tax gain.
Bath & Body Works, Inc. furnished an update on its business by releasing unaudited financial results for the second quarter of 2025 and revising its earnings outlook. The company issued a press release on August 28, 2025 that includes results for Q2 2025, earnings guidance for the third quarter of 2025, and updated earnings guidance for the full year 2025.
The information is provided under Items 2.02 (Results of Operations and Financial Condition) and 7.01 (Regulation FD Disclosure) and is designated as furnished rather than filed, which affects how it is treated under securities law. The press release is attached as Exhibit 99.1 to the report.